[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"snoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:snoring":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,47,80,114,137,162,188,209],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100561215","phase-2-study-to-examine-the-effect-of-silicone-mouth-tape-on-snoring-and-mild-sleep-apnea-100561215",false,"NCT06587256","Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.","Mouth Tape for Snoring and Sleep Apnea (MTASSA)","MTASSA","Inclusion Criteria:\n\n* Adult patients with a body mass index of 35 kg\u002Fm2 with a self-reported history of snoring and a bed partner who can provider answers to about the patients snoring. Patients must have a prior sleep study that shows no sleep apnea, or mild sleep apnea (AHI under 15 events\u002Fhr).\n\nExclusion Criteria:\n\n* Allergy to silicone mouth tape, chronic lung disease, facial hair preventing wearing of the tape\n* Grade 3+ or 4+ tonsils, prior palatal or tongue surgery.\n* Patients may not have any form of chronic or acute hypoventilation.\n* Patients must be able to tolerate breathing through their nose with the mouth tape in place for at least 3 minutes.\n* Patients may not be pregnant","ALL","18 Years","75 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"PHASE2","Snoring is a common problem caused by vibration of tissues in the throat region during sleep. Although snoring is sometimes dismissed as a minor nuisance rather than a medical disorder, several studies indicate that snoring can disrupt sleep quality of the snorer, as well as the snorer's bed partner. Snoring also might lead to problems such as dry mouth, bad breath, dental problems, and even cardiovascular disease. Current treatments for snoring include lifestyle modifications such as weight loss, side-sleeping, and avoidance of evening alcohol intake. In some cases, invasive surgeries, dental devices, or even CPAP are recommended for snoring. These interventions have mixed effectiveness and may be difficult to use.\n\nIt may be possible to treat snoring by fostering nasal breathing, while avoiding mouth-breathing during sleep. Breathing through the mouth reduces the airway diameter and contributes to snoring. Several studies show that nasal breathing can reduce snoring volume and improve airflow. Recent studies have shown that covering the mouth during sleep with adhesive patches or tape can improve snoring volume without adverse effects. However, these studies were performed in a small number of patients and did not fully measure the impact of the intervention on sleep quality, sleep architecture, or the experience of the bed partner, who is often the overlooked \"victim\" of the snoring. In this interventional study, the investigators will examine the safety and efficacy of mouth tape for snoring, focusing on subjective and objective snoring\u002Fbreathing metrics of both the snorer and bed partner.\n\nSnoring is sometimes also a sign of obstructive sleep apnea (OSA). If OSA is ruled out with a sleep study, patients are considered to have \"simple\" snoring. When OSA is mild (apnea hypopnea index 15), treatments can include the same interventions as snoring (e.g. weight loss, avoidance of alcohol, side-sleeping) or can be more aggressively treated with devices such as continuous positive airway pressure (CPAP). CPAP may be challenging to use, expensive, and associated with side effects such as mouth dryness and skin irritation. Alternative, inexpensive, and well-tolerated interventions are needed for mild OSA. For this reason, the investigators include patients with snoring and mild OSA in this study.",[28,29],"Mild Obstructive Sleep Apnea","Snoring",[31,32,33],"sleep apnea","snoring","mouth tape","RECRUITING","2026-06-18",{"date":37,"type":38},"2026-06-23","ACTUAL",{"date":40,"type":22},"2027-03-01",{"date":42,"type":22},"2030-10",{"name":44,"class":45},"Johns Hopkins University","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":23,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":79},"100640198","serene-sleep-palatal-implant-system-clinical-confirmatory-trial-in-participants-who-snore-or-are-diagnosed-with-mild-to-moderate-obstructive-sleep-apnea-osa-100640198","NCT07613281","Serene Sleep Palatal Implant System Clinical Confirmatory Trial in Participants Who Snore or Are Diagnosed With Mild-to-moderate Obstructive Sleep Apnea (OSA).","A Prospective, Non-Randomized, Multi-Center, Two-Arm Study Evaluating the Serene Sleep Palatal Implant System","INCLUSION CRITERIA\n\nA potential participant must meet ALL the following criteria to be enrolled into this study:\n\n1. Participant is ≥18 years of age.\n2. Participant has Body Mass Index (BMI) less than or equal to 30 kg\u002Fm²\n3. Participant has a tonsil grade less than or equal to 2\n4. Participant has a Friedman Tongue Position (FTP) I or II\n5. Participant is able to provide voluntary written informed consent.\n\nFor a snoring participant to be selected for the study:\n\n* Confirmed identification of palatal snoring\n\n  * Investigators will utilize standard of care clinical assessment methods to confirm the presence of palatal snoring prior to enrollment. These methods may include patient-reported history, physical examination of the upper airway, and auscultation or audio recordings.\n* Confirmed elimination of potential sleep apnea diagnosis\n\n  * If the evaluating doctor suspects that the participant may be experiencing OSA, investigators will utilize standard of care clinical assessment methods to confirm OSA.\n  * A resulting AHI \\\u003C5 would classify the participant as an eligible snoring subject\n\nFor an OSA participant to be selected for study:\n\nConfirmed identification of apnea caused by palatal collapse\n\n* Investigators should be able to make this identification through intraoral evaluation in accordance with their standard of care\n* Confirmed mild-to-moderate classification of OSA\n\n  * If the evaluating investigator knows or suspects that the participant may be experiencing OSA, standard of care diagnostic methods will be used as confirmation.\n  * A resulting AHI between 5 and 30 would classify the participant as an eligible OSA subject.\n\nEXCLUSION CRITERIA\n\nA potential participant will be excluded from enrollment if ANY of the following conditions apply:\n\n1. A record of allergic reaction to polyethylene terephthalate (PET) \u002F polyester\n2. An overly sensitive gag reflex\n3. Septal deviation or nasal obstruction\n4. Nasal polyps\n5. Severe seasonal allergies\n6. Soft palate length insufficient to accommodate implants\n7. Prior Diagnosis of Lingual tonsil hypertrophy\n8. Hypopharyngeal obstruction\n9. Previous pharyngeal surgery\n10. Previous upper respiratory tract cancer or radiation therapy\n11. Active respiratory tract infection\n12. Dysphagia or speech disorder\n13. Neurologic disorder\n14. Unstable psychiatric disorder\n15. Pregnant or breastfeeding\n16. History of falling asleep driving or Motor Vehicle Accident (MVA) due to sleepiness\n17. Clinical Presentation that suggests Severe OSAHS (ESS \\>20, participant report of choking or gasping during sleep, etc.)\n18. Marfan's Syndrome, Ehler-Danlos syndromes or other disorders of connective tissue and\u002For muscular tissue\n19. Other sleep disorders\n20. Other significant craniofacial anomaly\n21. Participant is participating in any of the following:\n\n    * A study with the same or similar primary endpoint\n    * Any study in which the investigator determines may interfere with the results of this study\n22. Participant is unwilling to complete all study related assessments and follow-up visits\n23. Participant is unwilling or unable to abstain from all alcohol consumption for 24 hours leading up to the intake sleep study\n24. Participant is unwilling or unable to abstain from all smoking, vaping, and\u002For oral tobacco products for 48 hours following the procedure\n25. Participant has any other medical condition which in the opinion of the Investigator will make participation medically unsafe or interfere with the study results",{"count":55,"type":22},26,[57],"NA","This clinical investigation is a prospective, non-randomized, parallel-group clinical investigation conducted at two (2) investigative sites. Study participants will be assigned to one of two study groups, snoring and obstructive sleep apnea, in a parallel manner based on predefined eligibility criteria.\n\nThe study aims to evaluate and compare outcomes between the two groups under investigation. The primary endpoint for this study is to evaluate the adverse event profile of the Serene Sleep Palatal Implants, in comparison to those observed with the previously marketed Pillar Palatal Implants, in subjects treated for snoring and\u002For mild-to-moderate OSA.\n\nThe design allows for the concurrent enrollment and follow-up of participants in both arms, enabling direct observation of differences in safety across the groups over time.",[29,60],"OSA - Obstructive Sleep Apnea",[29,62,63,64,65,66,67],"Obstructive Sleep Apnea","Sleep Apnea","Hypopnea","Sleep-Disordered Breathing","Sleep Implant","Airway Support Implant","NOT_YET_RECRUITING","2026-05-29",{"date":71,"type":38},"2026-06-01",{"date":73,"type":22},"2026-06",{"date":75,"type":22},"2026-10",{"name":77,"class":78},"Serene Sleep, Inc.","INDUSTRY",2,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":4,"eligibilityCriteria":86,"healthyVolunteers":87,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":88,"targetDuration":4,"studyType":23,"phases":90,"briefSummary":91,"conditions":92,"keywords":99,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":46},"100600934","ioa-preventing-occlusal-changes-with-mad-use-100600934","NCT07103941","IOA Preventing Occlusal Changes With MAD Use","Effectiveness of Interocclusal Aligner (IOA) on Preventing Occlusal Changes in Patients Treated With a Mandibular Advancement Device (MAD): A Preliminary Study","Inclusion Criteria:\n\n* adult participants (≥18 years)\n* diagnosed with SRBD and prescribed Mandibular Advancement Device (MAD) therapy\n* Participants will include patients with well restored natural dentition with all posterior teeth, excluding third molars, one missing premolar secondary to orthodontic treatment.\n\nExclusion Criteria:\n\n* pervious orthognathic surgery\n* anterior cross bite\n* posterior cross bite\n* existing open bite or implant supported restorations\n* tooth mobility\n* significant dental caries or periodontitis\n* severe bruxism\n* planned upcoming dental work including caps, crowns, implants, or braces\n* inadequate mandibular protrusion\n* severe micrognathia\n* large tori\n* significant claustrophobia\n* significant nasal obstruction\n* large oropharyngeal masses or large tonsils",true,{"count":89,"type":22},30,[57],"This study is evaluating two standard-of-care strategies used to prevent bite changes (occlusal changes) in patients treated with a Mandibular Advancement Device (MAD) for sleep-related breathing disorders such as obstructive sleep apnea (OSA). While MAD therapy is effective, it can lead to changes in how the teeth fit together, including the development of a posterior open bite.\n\nParticipants in this study will be randomly assigned to one of two standard-of-care approaches: using an interocclusal aligner each morning after removing the MAD, or performing daily jaw exercises. Both methods aim to reduce the risk of occlusal changes.\n\nThe study will follow participants over a 3-month period and includes dental evaluations, 3D oral scans, and short daily surveys. Findings from this research may help guide best practices for preserving occlusion during MAD therapy.",[93,29,94,95,96,97,98],"Sleep Related Breathing Disorder","Obstructive Sleep Apnea (OSA)","Open Bite","Occlusal Changes","Tooth Migration","Posterior Open Bite",[100,101,98,96,102,103,104,62],"Interocclusal Aligner","Mandibular advancement Device","Dental Changes","Protrusion","Sleep Appliance","2026-05-14",{"date":107,"type":38},"2026-05-18",{"date":109,"type":38},"2025-11-17",{"date":111,"type":22},"2026-12-30",{"name":113,"class":45},"Isabel Moreno Hay",{"id":115,"slug":116,"hasResults":11,"nctId":117,"briefTitle":118,"officialTitle":118,"acronym":4,"eligibilityCriteria":119,"healthyVolunteers":87,"sex":17,"minAge":120,"maxAge":4,"enrollmentInfo":121,"targetDuration":4,"studyType":23,"phases":123,"briefSummary":124,"conditions":125,"keywords":126,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":131,"completionDateStruct":133,"leadSponsor":135,"locationsCount":46},"100628841","effects-of-frequency-adjustment-in-functional-electrical-stimulation-on-genioglossus-muscle-activity-100628841","NCT07466888","Effects of Frequency Adjustment in Functional Electrical Stimulation on Genioglossus Muscle Activity","Inclusion Criteria:\n\n* Adults aged 19 years or older\n* STOP questionnaire score ≥ 2\n* Able to read and write in Korean\n* Voluntarily provides written informed consent to participate in the study\n\nExclusion Criteria:\n\n* Refusal to undergo study procedures or failure to provide informed consent\n* Cognitive impairment or psychiatric disorders that interfere with the ability to follow study instructions\n* Pregnant or breastfeeding women\n* Known allergy or hypersensitivity to electrical stimulation pads or related materials (e.g., silicone, polypropylene, polyethylene)\n* Skin conditions preventing application of electrical stimulation (e.g., hypersensitive skin)\n* Medical conditions considered unsuitable for participation by the investigator (e.g., epilepsy, malignant tumor, high fever, diabetes mellitus, use of anticoagulants, phlebitis, thrombophlebitis, hemophilia)\n* Infectious disease or local conditions at the stimulation site (e.g., inflammation, wounds, abscess, edema)\n* Known cardiac disease or presence of a cardiac pacemaker or implanted electrical stimulation device\n* History of surgery involving the submental area or upper airway region","19 Years",{"count":122,"type":22},28,[57],"This single-group interventional study investigates the safety and physiologic effects of functional electrical stimulation (FES) applied to the tongue and submental muscles in adults at high risk for sleep apnea. Participants will receive five stimulation frequencies (15, 25, 35, 45, and 75 Hz) in randomized order during a single visit. Ultrasound and tongue pressure (IOPI) measurements, as well as subjective assessments of discomfort and perceived effects, will be conducted before, during, and after stimulation. The primary objective is to evaluate changes in muscle thickness, length, and tongue strength across different stimulation frequencies. Secondary objectives include assessing participant discomfort, safety, and subjective treatment effects.",[94,29],[94,29,127],"FES","2026-03-08",{"date":130,"type":38},"2026-03-12",{"date":132,"type":38},"2026-01-06",{"date":134,"type":22},"2026-04",{"name":136,"class":45},"Seoul National University Bundang Hospital",{"id":138,"slug":139,"hasResults":11,"nctId":140,"briefTitle":141,"officialTitle":142,"acronym":143,"eligibilityCriteria":144,"healthyVolunteers":87,"sex":145,"minAge":18,"maxAge":146,"enrollmentInfo":147,"targetDuration":4,"studyType":23,"phases":149,"briefSummary":150,"conditions":151,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":46},"100335345","improving-sleep-quality-during-pregnancy-using-an-oral-appliance-100335345","NCT03646214","Improving Sleep Quality During Pregnancy Using an Oral Appliance","Oral Appliance Therapy for Improving Sleep Quality During Pregnancy: A Controlled Clinical Trial","PREGNCCT","Inclusion Criteria:\n\n* Pregnant adults who snore\n* At least 8 teeth per arch\n* Mallampati score from I to II\n* Palatine tonsils grade 0,1 or 2\n* Capable of giving verbal and written informed consent\n* Able to apply the sleep recorder and the oral appliance.\n\nExclusion Criteria:\n\n* Pregnant \\> 32 weeks\n* Uncontrolled serious health issues\n* Cardiovascular or cardiac rhythm disorders\n* Pharmacological dependency\n* Concomitant use of hypnotic agents or other sleep aids, nicotine or alcohol\n* Ongoing temporomandibular joint disorders\n* Loose teeth or periodontal disease\n* History of uvulopalatopharyngoplasty (UPPP)","FEMALE","45 Years",{"count":148,"type":22},20,[57],"Many pregnant women suffer from poor sleep quality and snoring. Evidence shows an increasing association between (1) sleep disordered breathing and (2) maternal cardiovascular disease and in-hospital death. Snoring is a variant of obstructive sleep apnea (OSA) and OSA during pregnancy is associated with higher risks for cesarean delivery, gestational hypertension, preeclampsia and preterm delivery. It may also impact fetal outcomes negatively. The purpose of this study is to determine whether sleep quality can be improved in pregnant women who snore by means of an oral appliance that opens the airway. Sleep quality is evaluated objectively using an un-intrusive home sleep test system.",[29,152],"Sleep Fragmentation","2025-10-01",{"date":155,"type":38},"2025-10-07",{"date":157,"type":38},"2018-02-01",{"date":159,"type":22},"2026-07-30",{"name":161,"class":45},"Texas A&M University",{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":4,"eligibilityCriteria":168,"healthyVolunteers":11,"sex":17,"minAge":169,"maxAge":4,"enrollmentInfo":170,"targetDuration":4,"studyType":23,"phases":172,"briefSummary":173,"conditions":174,"keywords":175,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":179,"lastUpdatePostDateStruct":180,"startDateStruct":182,"completionDateStruct":184,"leadSponsor":186,"locationsCount":46},"100561781","smart-pillows-for-enhancing-sleep-quality-100561781","NCT06594627","Smart Pillows for Enhancing Sleep Quality","Smart Pillows for Enhancing Sleep Quality_Pilot Study","Inclusion Criteria:\n\n* Inclusion criteria for individuals with snoring issues or OSA\n\n  * Individuals 50 years of age or older.\n  * Individuals who experience snoring issues and\u002For OSA that may impact their perceived sleep quality or that of their sleep partner.\n  * Individuals who currently use and do not use snoring and\u002For OSA treatment (participants will not be asked or required to discontinue any current snoring and\u002For OSA treatments that they are prescribed or using.)\n  * Individuals who have a smartphone or a smart mobile device (Apple iOS 15 and higher or Android 10 or higher).\n  * Individuals with and without a sleep partner.\n  * Individuals who do not have a pacemaker.\n  * Individuals who do not have intracranial electrodes.\n  * Individuals who do not have neck pain related to the cervical spine problems, including disc, muscle, and neurological issues.\n\nInclusion criteria for sleep partners\n\n* Individuals aged 18 years and older.\n* Individuals who share the same sleeping space with their sleep partner (who has snoring issues and\u002For OSA) more than four times a week.\n* Individuals whose sleep partner (who has snoring issues and\u002For OSA) agrees to participate in this study.\n\nExclusion Criteria:\n\n* Any participant who is not able to consent or complete study interventions independently, as determined by the investigator.","50 Years",{"count":171,"type":22},24,[57],"The purpose of this study is to examine the impact of smart pillows on the sleep quality of individuals who experience a snoring issue and\u002For obstructive sleep apnea (OSA), as well as their sleep partners. Furthermore, this study will explore whether enhancements in sleep quality positively influence depressive symptoms, physical activity, heart rate, blood oxygen levels, and cognitive functions.",[29,62],[176,177,32,178],"assistive device","sleep quality","obstructive sleep apnea","2025-08-22",{"date":181,"type":38},"2025-08-29",{"date":183,"type":38},"2024-11-18",{"date":185,"type":22},"2026-07-11",{"name":187,"class":45},"Indiana University",{"id":189,"slug":190,"hasResults":11,"nctId":191,"briefTitle":192,"officialTitle":193,"acronym":4,"eligibilityCriteria":194,"healthyVolunteers":87,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":195,"targetDuration":4,"studyType":197,"phases":4,"briefSummary":198,"conditions":199,"keywords":4,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":200,"lastUpdatePostDateStruct":201,"startDateStruct":203,"completionDateStruct":205,"leadSponsor":207,"locationsCount":4},"100600446","validation-of-a-snoring-app-against-commercially-available-applications-and-psg-100600446","NCT07097597","Validation of a Snoring App Against Commercially Available Applications and PSG","Clinical Validation of a Snoring-App Compared to a Sleep Study and a Commercially Available Application","Inclusion Criteria:\n\n* Referred for a diagnostic sleep study\n\nExclusion Criteria:\n\n* Under the age of 18",{"count":196,"type":22},60,"OBSERVATIONAL","This study will compare the output of a new snoring application against another commercially available application and polysomnography (either home or in-laboratory).",[29,94],"2025-07-24",{"date":202,"type":38},"2025-07-31",{"date":204,"type":22},"2025-09-01",{"date":206,"type":22},"2026-01-31",{"name":208,"class":45},"Windsor Sleep Disorders Clinic",{"id":210,"slug":211,"hasResults":11,"nctId":212,"briefTitle":213,"officialTitle":214,"acronym":215,"eligibilityCriteria":216,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":217,"enrollmentInfo":218,"targetDuration":4,"studyType":23,"phases":220,"briefSummary":221,"conditions":222,"keywords":226,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":232,"completionDateStruct":234,"leadSponsor":236,"locationsCount":46},"100494561","tolerance-and-benefits-of-mandibular-advanced-device-for-snoring-and-sleep-apnea-in-oropharyngeal-cancer-100494561","NCT05719779","Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.","Evaluation of the Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Patients With Oropharyngeal Cancer: Mixed Design Study.","Ronco-Onco","Inclusion Criteria:\n\n* oropharyngeal cancer diagnosis\n* 18 years of age and over\n* female or male; ratio of 1\u002F4 toward men\n* had received RTH in the Department of Radiation Oncology,\n* reporting snoring and\u002For respiratory cessation complaints during sleep,\n\nExclusion Criteria:\n\n* pregnant or breastfeeding woman;\n* edentation preventing retention of the oral appliance;\n* taking opioid or anxiolitic type medications;\n* history of major depression,\n* uncontrolled hypertension,\n* history of stroke;\n* under treatment with CPAP for sleep apnea;\n* regular and intense orofacial pain;\n* under pharmacological treatment for insomnia;\n* excessive alcohol or drug use (e.g., cannabis, opioid).","65 Years",{"count":219,"type":22},35,[57],"Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.",[223,224,63,29,225],"Oral Cancer","Pharynx Cancer","Oral Squamous Cell Carcinoma",[227,32,31,228],"oropharyngeal cancer","oral appliance","2024-08-14",{"date":231,"type":38},"2024-08-15",{"date":233,"type":38},"2023-02-03",{"date":235,"type":22},"2025-12-30",{"name":237,"class":45},"Centre hospitalier de l'Université de Montréal (CHUM)"]